Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2025-12-28 @ 5:52 AM
Study NCT ID:
NCT05876832
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-05-26
First Post:
2023-05-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of XY0206 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory AML With FLT3-ITD-Mutation (ALIVE)
Sponsor:
Shijiazhuang Yiling Pharmaceutical Co. Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-17
First Submit QC Date:
None
Study First Post Date:
2023-05-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-24
Last Update Post Date:
2023-05-26
Last Update Post Date Type:
ACTUAL